Clinical potential of proteomics in the diagnosis of ovarian cancer

Expert Review of Molecular Diagnostics

Volumn 2, Issue 4, 2002, Pages 312-320

  Ardekani, Ali M ^a   Liotta, Lance A ^a   Petricoin III, Emanuel F ^a  

^a Building 29A ^*  (United States)

Author keywords

Diagnostics; Ovarian cancer; Proteomics

Indexed keywords

BIOLOGICAL MARKER; BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN; TUMOR MARKER;

ARTIFICIAL INTELLIGENCE BASED INFORMATIC ALGORITHM; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; MASS SPECTROMETRY; OVARY CANCER; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; BIOLOGY; BLOOD; FEMALE; FORECASTING; GENETICS; HUMAN; OVARY TUMOR;

CA-125 ANTIGEN; COMPUTATIONAL BIOLOGY; FEMALE; FORECASTING; HUMANS; OVARIAN NEOPLASMS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036020072     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.2.4.312     Document Type: Review

References (45)

1. The sequence of the human genome
2. Initial sequencing and analysis of the human genome
3. Expression profiles of active genes in human and mouse livers
4. In vivo gene expression profile analysis of human breast cancer progression
5. A comparison of selected mRNA and protein abundances in human liver
6. Epidemiology of gynecologic cancers
7. Recombinant humanized antiHER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
8. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
9. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
10. Hepatocyte-derived soluble factors regulate proliferation and autocrine growth factor expression in colon cancer cell lines of varying liver-colonizing capability
11. Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion
12. The microenvironment of the tumour-host interface
13. Laser capture microdissection
14. Laser capture microdissection: Molecular analysis of tissue
15. Immuno-LCM: Laser capture microdissection of immunostained frozen sections for mRNA analysis
16. Two-dimensional electrophoresis: The state of the art and future directions
17. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip
18. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
19. Clinical proteomics: Personalized molecular medicine
20. An approach to proteomic analysis of human tumors
21. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary finding
22. New approaches to proteomic analysis of breast cancer
23. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry
24. Cancer statistics, 2001
25. Reproductive technologies and risk of ovarian cancer
26. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three US population-based case-control studies in ovarian cancer
27. Breast and ovarian cancer incidence in BRCA1-mutation carriers
28. The genetics of breast cancer susceptibility
29. Prognostic factors in ovarian cancer
30. Management of borderline tumors of the ovary state of the art
31. Screening for ovarian cancer: A pilot randomized trial
32. Developments in the pathology of ovarian tumours
33. Recent developments in ovarian cancer screening
34. Ovarian cancer
35. Ovarian cancer screening in the general population
36. Is early detection of ovarian cancer possible?
37. Survival among US women with invasive epithelial ovarian cancer
38. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer
39. Composition of the peptide fraction in human blood plasma: Database of circulating human peptides
40. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
41. Proteomic patterns in sera detect early stage ovarian cancer
42. Transvaginal sonography as a screening method for the detection of early ovarian cancer
43. Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction
44. Ovarian cancer screening